ImmuneWatch Revenue

Biotechnology Research • Antwerp, Flemish Region, Belgium • 1-10 Employees

ImmuneWatch revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	No funding

Key Contacts at ImmuneWatch

Sander Wuyts

Ceo And Co-Founder

Tom Bosschaerts

Director Of Operations

Company overview

Headquarters	Antwerp, Flemish Region, Belgium
Phone number	+32774472942
Website	immunewatch.com
NAICS	541714
Founded	2021
Employees	1-10
Socials

ImmuneWatch Email Formats

ImmuneWatch uses 1 email format. The most common is {first initial} (e.g., j@immunewatch.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@immunewatch.com	100%

About ImmuneWatch

ImmuneWatch supports academics, clinical-stage biotech and pharma companies by using machine learning to identify T-cell receptor targets and analyse immune responses, helping improve (cancer) vaccines and immunotherapies.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

ImmuneWatch has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

ImmuneWatch has never raised funding before.

ImmuneWatch Tech Stack

Discover the technologies and tools that power ImmuneWatch's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Workspace

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

Webflow

Page builders

Google Analytics

Analytics

Cart Functionality

Ecommerce

Leaflet

Maps

jsDelivr

CDN

Frequently asked questions

ImmuneWatch is located in Antwerp, Flemish Region, BE.

You can reach ImmuneWatch at +32774472942.

ImmuneWatch generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.

ImmuneWatch has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ImmuneWatch was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

ImmuneWatch has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at ImmuneWatch

Sander Wuyts

Ceo And Co-Founder

Tom Bosschaerts

Director Of Operations

4.8

40,000 users